NASDAQ:PRPO - Precipio Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.21 -0.01 (-4.55 %) (As of 01/16/2019 09:38 AM ET)Previous Close$0.2230Today's Range$0.2105 - $0.2352-Week Range$0.15 - $1.75Volume711,834 shsAverage Volume3.11 million shsMarket Capitalization$6.81 millionP/E RatioN/ADividend YieldN/ABeta0.72 ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer. The company is based in New Haven, Connecticut. Receive PRPO News and Ratings via Email Sign-up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Analytical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PRPO Previous Symbol CUSIPN/A Webwww.precipiodx.com Phone203-787-7888Debt Debt-to-Equity Ratio0.30 Current Ratio0.14 Quick Ratio0.13Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.72 million Price / Sales3.71 Cash FlowN/A Price / Cash FlowN/A Book Value$1.28 per share Price / Book0.16Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-20,690,000.00 Net Margins-610.39% Return on Equity-149.24% Return on Assets-68.66%Miscellaneous Employees33 Outstanding Shares30,380,000Market Cap$6.81 million OptionableNot Optionable Precipio (NASDAQ:PRPO) Frequently Asked Questions What is Precipio's stock symbol? Precipio trades on the NASDAQ under the ticker symbol "PRPO." When did Precipio's stock split? How did Precipio's stock split work? Precipio's stock reverse split before market open on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split. How were Precipio's earnings last quarter? Precipio Inc (NASDAQ:PRPO) announced its quarterly earnings data on Monday, November, 19th. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $0.65 million for the quarter. Precipio had a negative return on equity of 149.24% and a negative net margin of 610.39%. View Precipio's Earnings History. When is Precipio's next earnings date? Precipio is scheduled to release their next quarterly earnings announcement on Monday, February 18th 2019. View Earnings Estimates for Precipio. Has Precipio been receiving favorable news coverage? News coverage about PRPO stock has trended very positive on Wednesday, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Precipio earned a news sentiment score of 3.7 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. Who are some of Precipio's key competitors? Some companies that are related to Precipio include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM) and Eyepoint Pharmaceuticals (EYPT). Who are Precipio's key executives? Precipio's management team includes the folowing people: Mr. Ilan Danieli, Founder, Pres, CEO & Director (Age 46)Mr. Carl R. Iberger, CFO & Sec. (Age 65)Mr. Ahmed Zaki Sabet, Chief Operating Officer (Age 32)Mr. Douglas Sites, VP of SalesMr. Ayman Mohamed, Sr. VP of R&D and Laboratory Operations (Age 33) How do I buy shares of Precipio? Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Precipio's stock price today? One share of PRPO stock can currently be purchased for approximately $0.2230. How big of a company is Precipio? Precipio has a market capitalization of $6.81 million and generates $1.72 million in revenue each year. Precipio employs 33 workers across the globe. What is Precipio's official website? The official website for Precipio is http://www.precipiodx.com. How can I contact Precipio? Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The biotechnology company can be reached via phone at 203-787-7888 or via email at [email protected] MarketBeat Community Rating for Precipio (NASDAQ PRPO)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 161 (Vote Outperform)Underperform Votes: 112 (Vote Underperform)Total Votes: 273MarketBeat's community ratings are surveys of what our community members think about Precipio and other stocks. Vote "Outperform" if you believe PRPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/16/2019 by MarketBeat.com StaffFeatured Article: What is a Market Correction?